| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1600059 | 重组人TNFα单克隆抗体注射液 | adalimumab | Injection | Biological Products(2) | New Drug Application | 2016-09-12 | 海南赛乐敏生物科技有限公司 | Hainan Sailemin Biotechnology Co Ltd | Certificate Issued | 2017-12-21 | view |